Weekly Digest – September 2025 Weekly Digest – September 2025 16 September 2025: Adagene expands SAFEbody collaboration and license agreement with Exelixis to develop third novel masked antibody-drug conjugate Adagene announced an amendment to its 2021 collaboration and license agreement with […]
Weekly Digest – September 2025 Weekly Digest – September 2025 15 September 2025: Spera Pharma and Mycenax forge strategic alliance to streamline ADC drug substance and drug product manufacturing services Spera Pharma and Mycenax Biotech have formed a strategic alliance […]
Weekly Digest – September 2025 Weekly Digest – September 2025 15 September 2025: Biocytogen announces ADC innovator Tubulis has signed global exclusive license agreement for single antibody Biocytogen announced that Tubulis has exercised an exclusive license for the global development […]
